Lexington, MA, United States of America

Fred Spaziani

This inventor holds 2 USPTO granted patents. Top assignees: Nova Biomedical Corporation, Other. Active years: 1987-1988.


% Patents Active = 100.0

Average Co-Inventor Count = 1.8

ph-index = 2

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 1987-1988

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fred Spaziani: Innovator in Automated Chemistry Analysis

Introduction

Fred Spaziani is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of automated chemistry analysis, particularly in the analysis of blood components. With a total of 2 patents, his work has advanced the capabilities of medical diagnostics.

Latest Patents

Fred Spaziani's latest patents include an automated chemistry analyzer designed for the analysis of blood components. This innovative apparatus and control kit allows for the measurement of hematocrit levels in blood samples. The process involves flowing the sample along a liquid flow path and utilizing electrodes to obtain electrical signals that represent the sample's electrical conductivity and ion concentration. The system derives a tentative hematocrit value, which is then corrected using standardizing signals. A control solution with known ion concentration is employed to evaluate the hematocrit detection apparatus, enhancing the accuracy of the measurements.

Career Highlights

Throughout his career, Fred has worked with various companies, including Nova Biomedical Corporation. His expertise in automated analysis has positioned him as a key player in the development of medical diagnostic technologies.

Collaborations

Fred has collaborated with notable individuals in his field, including Chung Chang Young and Robert L Coleman. Their combined efforts have contributed to advancements in automated chemistry analysis.

Conclusion

Fred Spaziani's innovative work in automated chemistry analysis has made a significant impact on medical diagnostics. His patents reflect a commitment to improving the accuracy and efficiency of blood component analysis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…